MPS share price today

MPS Ltd's share price was ₹2,315.90 at the close on 4 November 2026. It has been rising for 15 weeks. That is 2.5% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹1,393 and ₹2,931, and at that close it sat 60% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today MPS Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 4 weeks running.

Over the last 11 years the share price moved +253% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Best operating margin in 13 quarters

   Operating margin was 34% in the June 2026 quarter, against 27% a year earlier.

   Why: Margins rose because revenue grew much faster than staff numbers, so the same team handled more work.

   Next results: check second quarter operating profit and margin against the FY27 floor of Rs 300 crore.

   From the earnings call on 22 Jul 2026.

3. Highest quarterly revenue in 15 quarters

   Revenue of ₹224 crore in the June 2026 quarter is the highest of the last 15 quarters.

   Why: Revenue hit a record because education work grew strongly, helped by Unbound's first full quarter and more content, accessibility and AI learning projects.

   Next results: check whether the AJE business settles and whether early peer review demand turns into more research revenue.

   From the earnings call on 22 Jul 2026.

For April to June 2026 (the quarter ended 30 June 2026), MPS reported revenue of ₹224 crore, up 20.4% from ₹186 crore a year earlier, and a profit of ₹50.0 crore, up 42.9% from ₹35.0 crore.

MPS results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

MPS' management discussed these results on a call held on 22 July 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

MPS closed at ₹2,315.90 on 4 November 2026, up 3.1% from ₹2,246.50 a year earlier (7 November 2025) and up 221.2% over five years. Its highest weekly close since March 2016 was ₹2,931.20 on 7 August 2026.

MPS share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

561 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: MPS closed at ₹2,315.90, down 0.2% on the week and down 11.9% on the month. 22 Jul 2026: MPS held its results call for April to June 2026. Management guided: FY27 consolidated operating profit to comfortably cross ₹300 crore.0% three-year operating profit yearly growth from FY24 to FY27.

Earlier

• Results for April to June 2026: Revenue up 20.4% and profit up 42.9% on a year earlier.

MPS paid no dividend in the 12 months to 5 November 2026. The last was a dividend of ₹50 a share, ex-date 13 August 2025.

MPS dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Not in its latest year. MPS Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 10 of its last 13 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 22 July 2026, MPS' management guided: FY27 consolidated operating profit to comfortably cross ₹300 crore.0% three-year operating profit yearly growth from FY24 to FY27.

“We run MPS on one principle when it comes to AI: it should show up in our revenue, not on slides.”Rahul Arora, Chairman and CEO, on the call for April to June 2026

What management guided

• MPS is hopeful of clearing the Rule of 50 for full-year FY27 but will not promise that every quarter clears the threshold.
• FY28 revenue of ₹1,500 crore and operating profit of more like ₹450 crore.
• Corporate learning steady-state goal is 30.0% operating margin with 10.0%-12.0% organic growth, driven by AI-enabled immersive solutions, account depth, and operating leverage.
• Unbound margins are expected to rise from the current 18.0%-20.0% range toward a mid-20s to late-20s operating margin for Rule of 40, with an eventual Rule of 50 ambition.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 22 July 2026.

Consolidated operating profit falling below ₹70 Cr in two consecutive quarters, or operating cash flow conversion (operating cash flow/profit) dropping below 0.70x, which would indicate that AI productivity gains are being competed away and pricing power is eroding.

Each change stops working if

• : Academic publishing houses build proprietary in-house verification layers or paper-mill detection models become open-source commodities.
• : Unbound renewal rates drop below 90% or cross-sales into Liberate and corporate learning fails to scale past early discussions.
• : Enterprise discretionary L&D budgets face macro contraction or organic growth fails to accelerate toward the 10.0%-12.0% goal from current 6.9%.

The main risks

• : Board decision to withhold final FY26 dividend to fund a 35-company M&A pipeline shifts shareholder return profile from high dividend payout to inorganic execution risk. ⚠ estimate
• : Unbound Medicine margin progression to the 25-30% company average has become less defined in concall commentary, remaining at 18-20% in April to June 2026. ⚠ estimate
• : Corporate Learning organic revenue growth of 6.9% in April to June 2026 lags behind the broader enterprise learning market growth rate of 12-13%. ⚠ estimate

Our read after the latest results, written 22 August 2026.

When MPS reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 consolidated operating profit and margin pace against the FY27 ₹300 crore floor; management expects the second half to outrun the first, so quarterly performance should remain ahead of a straight-line path.

MPS is not on any of our India lists this week.

MPS Ltd earned ₹50.0 Cr of net profit in the Jun 2026 quarter, +42.9% on the same quarter a year earlier. Full-year FY26 profit was ₹173 Cr. Over 10 years profit has grown 9.3% a year on average. That is 22.3% of the quarter's revenue. The same quarter a year earlier earned ₹35.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹173 Cr (+16.1% on the year before).

Why profit moved: revenue changed +20.4% on a year earlier and the margin moved +7.0 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +22.0% and revenue +9.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

FY26-Q4. revenue ₹205 Cr and profit ₹47 Cr as reported.

FY27-Q1. revenue ₹224 Cr and profit ₹50 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

MPS Ltd reported ₹224 Cr of revenue in the Jun 2026 quarter, +20.4% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 10 years it has grown 11.6% a year on average. The last full year, FY26, came in at ₹768 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. The $15.18M acquisition of Unbound Medicine expands MPS into medical informatics and clinical decision support. Unbound brings 1,000+ institutional accounts (medical schools, nursing schools, hospitals) with 97% customer retention. Initial consolidation in Q1 FY27 delivered an $800,000 monthly revenue run rate at 18.0%-20.0% EBITDA margins (up from 14% standalone baseline). Management has 35 companies under evaluation with 2 live goals in the ₹300-500 Cr range.

The last four reported quarters add to ₹805 Cr.

FY26 revenue was ₹768 Cr, +5.6% on the year before.

Recent pace: the last four quarters grew +9.9% on average, against 11.6% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +10.0%, against +16.4% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +19.0%, against +27.9% a year (rolling over).

FY26-Q4. revenue ₹205 Cr and profit ₹47 Cr as reported.

FY27-Q1. revenue ₹224 Cr and profit ₹50 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

MPS Ltd's operating margin was 34.0% in the Jun 2026 quarter, 7.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 24.0% and 36.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. MPS has deployed live AI tooling across its delivery stack rather than running speculative pilot projects. In Research Solutions, automated alt-text generation, one-touch production workflows, and automated quality checks have allowed volume throughput to expand without a proportional cost increase. In Corporate Learning, the shift to AI-assisted authoring and gig capacity permitted a 33% headcount reduction while expanding EBITDA margin to 25.3%. Operating leverage is confirmed by revenue growing 20.0% while headcount increased less than 3.0%.

Why the margin moved: operating margin changed +7.3 percentage points on the year while gross margin changed +0.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY26-Q4. revenue ₹205 Cr and profit ₹47 Cr as reported.

FY27-Q1. revenue ₹224 Cr and profit ₹50 Cr as reported.

Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.

Over the last 3 years, 94% of MPS Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹197 Cr of operating cash against ₹173 Cr of profit. After ₹222 Cr of spending on assets, free cash was −₹25.0 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 94% of profit came in as cash: the cash cycle got 15 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 5.9× depreciation over three years. The next section checks what that spending is building.

MPS Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 63 days in FY26, down from 78 days in FY21. It spent ₹442 Cr on assets over the last 3 years.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹768 Cr, each day of that cycle ties up about ₹2.1 Cr, so roughly ₹133 Cr is tied up in the business at any time.

Spending on assets: ₹442 Cr over the last 3 years, against ₹75.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

MPS Ltd's P/E is 21.6×, near the high end of its own history: higher than 78% of past readings. Its usual P/E (the middle reading) is 16.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹110.12.